RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus (SLE) an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. Its products in various stages of development i...
Industry: Biotechnology
Sector: Healthcare
Phone: 86 53 5611 3511
Fax: 86 53 5611 3517
Address:
58 Middle Beijing Road, Yantai Development Zone Yantai Area of Shandong Pilot Free Trade, Yantai, China
